These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8248641)

  • 41. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of chronic glomerulonephritis with small doses of acetylsalicylic acid].
    Petrů I; Knotková V; Nĕmecek K; Jáchymová M
    Cas Lek Cesk; 1990 Jun; 129(26):820-3. PubMed ID: 2393892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
    Chan MK; Kwan SY; Chan KW; Yeung CK
    Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis].
    Kacprzyk F; Kubala L; Chrzanowski W; Pastuszko-Maryniarczyk T
    Pol Tyg Lek; 1987 Aug; 42(34):1046-9. PubMed ID: 3422838
    [No Abstract]   [Full Text] [Related]  

  • 45. [Some problems of the therapy of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1987; 59(11):66-71. PubMed ID: 3441869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chronic progressive renal failure. 2. Chemotherapy of chronic active (progressive) glomerulonephritis].
    Koyama A; Iitsuka T
    Nihon Naika Gakkai Zasshi; 1993 Nov; 82(11):1830-6. PubMed ID: 8245612
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antiplatelet drugs in the treatment of glomerulonephritis].
    Małyszko J; Borawski J
    Przegl Lek; 1992; 49(8):274-5. PubMed ID: 1302348
    [No Abstract]   [Full Text] [Related]  

  • 48. Are antiplatelet agents of value in the treatment of chronic glomerular disease?
    Grekas D; Alivanis P; Kalekou H; Syrganis C; Tourkantonis A
    Nephrol Dial Transplant; 1987; 2(5):377-9. PubMed ID: 3122119
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hyperkeratosis of the keratotic plug type in patients with chronic renal failure and metabolic diseases].
    Noble JP; Guillemette J; Eisenmann D; Agulhon F; Ducasse MF; Adhemar J; Rottembourg J; Hewitt J
    Ann Dermatol Venereol; 1982; 109(5):471-7. PubMed ID: 7137795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelets, antiplatelet therapy, and diabetic nephropathy.
    Nath KA
    Mayo Clin Proc; 1988 Jan; 63(1):80-5. PubMed ID: 3275846
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of antiplatelet agents in glomerulonephritis: a pharmacological approach.
    Patrono C; Pierucci A
    Nephrol Dial Transplant; 1990; 5 Suppl 1():29-32. PubMed ID: 2129455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW; Moorthy AV; Dreher WH; Friedman A; Varanasi U
    Am J Med; 1983 Dec; 75(6):920-7. PubMed ID: 6359877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preliminary study on the relation of nephroglomerular diseases and audition].
    Guan Y
    Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):338-42. PubMed ID: 2169985
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment with platelet aggregation inhibitors in renal diseases].
    Nestor G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(6):429-34. PubMed ID: 14380
    [No Abstract]   [Full Text] [Related]  

  • 55. Anticoagulants in "irreversible" acute renal failure.
    Kincaid-Smith P; Saker BM; Fairley KF
    Lancet; 1968 Dec; 2(7583):1360-3. PubMed ID: 4177930
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of curantyl in diffuse glomerulonephritis].
    Zorina SS; Orlova NN; Krasik IaD
    Klin Med (Mosk); 1977 May; 55(5):122-6. PubMed ID: 875323
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effects of propaxoline on the renal function. Study on a group of patients with chronic or prolonged glomerulonephritis].
    Huber W; Laurini G; Romagnoli GF
    G Clin Med; 1972 Jan; 53(1):24-30. PubMed ID: 4639354
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnosis of the degree of renal failure in glomerulo- and pyelonephritis patients].
    Kulganov VA
    Voen Med Zh; 1984 Mar; (3):73. PubMed ID: 6730363
    [No Abstract]   [Full Text] [Related]  

  • 59. [Kidney and hemostasis. II. Therapeutic approach to various immunological renal diseases with blood platelet aggregation inhibitors].
    De Gaetano G; Donati MB; Vermylen J; Dotremont G; Michielsen P
    Clin Ter; 1972 Dec; 63(5):425-35. PubMed ID: 4566418
    [No Abstract]   [Full Text] [Related]  

  • 60. [Post-glomerulonephritis renal sclerosis. Chronic dialysis].
    Rev Clin Esp; 1967 Jan; 104(1):77-9. PubMed ID: 5596052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.